Details for: R3HDM1
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 58.11rCSI 72.29%PRS 54.42
-
CSI 57.05rCSI 68.15%PRS 56.42
-
CSI 51.07rCSI 65.84%PRS 57.71
-
CSI 43.86rCSI 70.54%PRS 58.18
-
CSI 41.53rCSI 69.71%PRS 56.45
-
CSI 37.44rCSI 66.12%PRS 55.64
-
CSI 36.43rCSI 79.03%PRS 62.37
-
CSI 33.19rCSI 79.38%PRS 61.57
-
CSI 31.22rCSI 24.06%PRS 77.42
-
CSI 29.35rCSI 71.33%PRS 54.54
-
CSI 25.58rCSI 68.11%PRS 62.82
-
CSI 23.32rCSI 72.94%PRS 60.67
-
CSI 23.3rCSI 76.58%PRS 61.24
-
CSI 23.17rCSI 72.41%PRS 58.18
-
CSI 21.77rCSI 44.75%PRS 62.92
-
CSI 20.64rCSI 45.6%PRS 60.55
-
CSI 20.02rCSI 72.05%PRS 54.5
-
CSI 18.66rCSI 70.52%PRS 56.85
-
CSI 16.52rCSI 19.1%PRS 66.74
-
CSI 15.63rCSI 12.12%PRS 78.54
-
CSI 15.16rCSI 24.19%PRS 66.71
-
CSI 14.7rCSI 25.92%PRS 70.99
-
CSI 14.5rCSI 31.91%PRS 58.45
-
CSI 14.25rCSI 9.91%PRS 86.43
-
CSI 14rCSI 29.05%PRS 72.06
-
CSI 13.48rCSI 31.12%PRS 63
-
CSI 13.29rCSI 9.87%PRS 86.81
-
CSI 13.18rCSI 10.65%PRS 84.61
-
CSI 13.13rCSI 8.72%PRS 78.05
-
CSI 13.02rCSI 12.02%PRS 76.71
-
CSI 12.76rCSI 25.35%PRS 71.21
-
CSI 12.68rCSI 21.93%PRS 65.94
-
CSI 11.74rCSI 69.11%PRS 57.3
-
CSI 11.71rCSI 40.11%PRS 61.84
-
CSI 11.56rCSI 10.15%PRS 80.38
-
CSI 11.45rCSI 29.6%PRS 70.2
-
CSI 11.33rCSI 29.52%PRS 70.46
-
CSI 10.51rCSI 55.25%PRS 67.61
-
CSI 10.33rCSI 8.86%PRS 81.95
-
CSI 10.15rCSI 50.46%PRS 70.39
-
CSI 9.91rCSI 44.05%PRS 75.47
-
CSI 9.6rCSI 12.33%PRS 65.6
-
CSI 9.56rCSI 11.55%PRS 83.39
-
CSI 9.47rCSI 69.59%PRS 61.81
-
CSI 9.21rCSI 16.55%PRS 68.14
-
CSI 9.01rCSI 14.49%PRS 64.65
-
CSI 8.8rCSI 32.95%PRS 67.11
-
CSI 8.74rCSI 6.65%PRS 87.69
-
CSI 8.7rCSI 51.35%PRS 67.73
-
CSI 8.62rCSI 8.86%PRS 88.09
-
CSI 8.58rCSI 17.22%PRS 64.62
-
CSI 8.48rCSI 19.4%PRS 75.77
-
CSI 8.23rCSI 11.44%PRS 73.66
-
CSI 8.19rCSI 12.93%PRS 76.86
-
CSI 8.15rCSI 70.18%PRS 62.15
-
CSI 8.11rCSI 6.41%PRS 62.84
-
CSI 8.11rCSI 9.37%PRS 67.17
-
CSI 7.96rCSI 11.29%PRS 71.46
-
CSI 7.78rCSI 51.64%PRS 70.51
-
CSI 7.74rCSI 12%PRS 80.1
-
CSI 7.7rCSI 9.87%PRS 78.77
-
CSI 7.48rCSI 50.89%PRS 68.83
-
CSI 7.46rCSI 6.46%PRS 79.57
-
CSI 7.41rCSI 16.92%PRS 66.24
-
CSI 7.39rCSI 9.48%PRS 71.36
-
CSI 7.16rCSI 14.53%PRS 53.16
-
CSI 7.06rCSI 13.22%PRS 62.81
-
CSI 7.01rCSI 10.69%PRS 71.68
-
CSI 6.91rCSI 5.12%PRS 67.99
-
CSI 6.81rCSI 14.98%PRS 79.19
-
CSI 6.75rCSI 5.59%PRS 77.61
-
CSI 6.6rCSI 36.09%PRS 72.3
-
CSI 6.5rCSI 11.39%PRS 68.01
-
CSI 6.45rCSI 11.54%PRS 74.33
-
CSI 6.4rCSI 21.43%PRS 59.04
-
CSI 6.2rCSI 23.41%PRS 58.16
-
CSI 6.14rCSI 5.38%PRS 83.01
-
CSI 6.13rCSI 9.79%PRS 78.82
-
CSI 6.04rCSI 9.6%PRS 67.65
-
CSI 5.72rCSI 15.17%PRS 82.13
-
CSI 5.71rCSI 44.2%PRS 70.06
-
CSI 5.61rCSI 6.99%PRS 84.84
-
CSI 5.59rCSI 42.05%PRS 67
-
CSI 5.49rCSI 13.41%PRS 67.83
-
CSI 5.47rCSI 12.27%PRS 57.13
-
CSI 5.42rCSI 5.22%PRS 74.42
-
CSI 5.37rCSI 17.79%PRS 79.98
-
CSI 5.32rCSI 21.69%PRS 67.37
-
CSI 5.32rCSI 13.17%PRS 74.29
-
CSI 5.28rCSI 3.79%PRS 88.09
-
CSI 5.27rCSI 20.62%PRS 52.61
-
CSI 5.25rCSI 3.1%PRS 90.61
-
CSI 5.18rCSI 9.41%PRS 65.99
-
CSI 5.07rCSI 11.11%PRS 81.23
-
CSI 5.05rCSI 7.51%PRS 75.46
-
CSI 4.99rCSI 19.75%PRS 71.77
-
CSI 4.98rCSI 7.37%PRS 79.82
-
CSI 4.9rCSI 13.94%PRS 71.48
-
CSI 4.83rCSI 7.29%PRS 80.46
-
CSI 4.8rCSI 27.68%PRS 72.36
-
CSI 0.3rCSI 1.5%PRS 80.7%
-
CSI 0.5rCSI 2.0%PRS 91.2%
-
CSI 0.7rCSI 1.4%PRS 78.3%
-
CSI 0.7rCSI 7.8%PRS 71.8%
-
CSI 0.9rCSI 5.4%PRS 66.5%
-
CSI 0.9rCSI 1.7%PRS 84.1%
-
CSI 0.9rCSI 4.6%PRS 77.5%
-
CSI 0.9rCSI 3.9%PRS 85.4%
-
CSI 1.0rCSI 2.1%PRS 74.1%
-
CSI 1.0rCSI 3.2%PRS 78.1%
-
CSI 1.1rCSI 10.0%PRS 63.5%
-
CSI 1.2rCSI 3.0%PRS 68.6%
-
CSI 1.2rCSI 6.0%PRS 83.9%
-
CSI 1.3rCSI 1.6%PRS 72.5%
-
CSI 1.4rCSI 4.9%PRS 94.8%
-
CSI 1.4rCSI 12.2%PRS 70.3%
-
CSI 1.5rCSI 11.8%PRS 68.7%
-
CSI 1.5rCSI 2.3%PRS 74.1%
-
CSI 1.5rCSI 3.6%PRS 79.4%
-
CSI 1.6rCSI 4.3%PRS 80.8%
-
CSI 1.6rCSI 6.1%PRS 65.5%
-
CSI 1.6rCSI 2.5%PRS 79.3%
-
CSI 1.7rCSI 4.8%PRS 92.0%
-
CSI 1.7rCSI 10.6%PRS 83.3%
-
CSI 1.8rCSI 4.5%PRS 90.7%
-
CSI 2.0rCSI 5.6%PRS 82.2%
-
CSI 2.1rCSI 5.3%PRS 72.4%
-
CSI 2.1rCSI 6.7%PRS 72.1%
-
CSI 2.1rCSI 3.2%PRS 75.4%
-
CSI 2.1rCSI 9.3%PRS 63.7%
-
CSI 2.2rCSI 7.3%PRS 73.4%
-
CSI 2.3rCSI 14.6%PRS 73.1%
-
CSI 2.4rCSI 6.4%PRS 66.1%
-
CSI 2.5rCSI 3.1%PRS 82.1%
-
CSI 2.6rCSI 3.8%PRS 80.1%
-
CSI 2.6rCSI 2.5%PRS 77.9%
-
CSI 2.6rCSI 2.0%PRS 88.3%
-
CSI 2.6rCSI 22.2%PRS 64.4%
-
CSI 2.7rCSI 3.6%PRS 84.8%
-
CSI 2.7rCSI 4.7%PRS 81.4%
-
CSI 2.7rCSI 3.7%PRS 66.5%
-
CSI 2.7rCSI 4.0%PRS 88.4%
-
CSI 2.7rCSI 13.1%PRS 72.3%
-
CSI 2.8rCSI 7.3%PRS 82.7%
-
CSI 2.8rCSI 67.8%PRS 55.6%
-
CSI 2.8rCSI 68.0%PRS 55.0%
-
CSI 2.8rCSI 7.8%PRS 69.9%
-
CSI 2.9rCSI 2.5%PRS 85.0%
-
CSI 2.9rCSI 4.5%PRS 84.2%
-
CSI 3.0rCSI 3.8%PRS 84.5%
-
CSI 3.1rCSI 2.9%PRS 90.5%
-
CSI 3.1rCSI 7.4%PRS 75.3%
-
CSI 3.1rCSI 63.7%PRS 66.1%
-
CSI 3.2rCSI 64.6%PRS 64.6%
-
CSI 3.2rCSI 9.0%PRS 70.5%
-
CSI 3.2rCSI 13.5%PRS 67.3%
-
CSI 3.2rCSI 7.8%PRS 89.1%
-
CSI 3.3rCSI 16.3%PRS 87.1%
-
CSI 3.3rCSI 2.3%PRS 78.5%
-
CSI 3.3rCSI 23.6%PRS 67.0%
-
CSI 3.3rCSI 2.7%PRS 77.3%
-
CSI 3.4rCSI 13.5%PRS 77.4%
-
CSI 3.4rCSI 7.5%PRS 84.5%
-
CSI 3.4rCSI 8.9%PRS 76.7%
-
CSI 3.5rCSI 3.6%PRS 78.4%
-
CSI 3.5rCSI 7.3%PRS 73.5%
-
CSI 3.6rCSI 2.4%PRS 88.1%
-
CSI 3.6rCSI 2.7%PRS 81.2%
-
CSI 3.6rCSI 15.9%PRS 70.7%
-
CSI 3.7rCSI 20.6%PRS 60.5%
-
CSI 3.7rCSI 41.8%PRS 64.7%
-
CSI 3.7rCSI 15.0%PRS 74.5%
-
CSI 3.8rCSI 18.1%PRS 74.9%
-
CSI 3.8rCSI 11.7%PRS 80.3%
-
CSI 3.8rCSI 4.7%PRS 76.4%
-
CSI 3.8rCSI 8.5%PRS 82.8%
-
CSI 3.9rCSI 2.7%PRS 89.1%
-
CSI 3.9rCSI 10.0%PRS 65.0%
-
CSI 4.0rCSI 3.7%PRS 75.8%
-
CSI 4.1rCSI 6.8%PRS 79.8%
-
CSI 4.1rCSI 5.4%PRS 86.9%
-
CSI 4.2rCSI 5.7%PRS 67.0%
-
CSI 4.2rCSI 19.7%PRS 68.3%
-
CSI 4.2rCSI 16.2%PRS 85.6%
-
CSI 4.3rCSI 60.7%PRS 65.7%
-
CSI 4.3rCSI 11.3%PRS 75.6%
-
CSI 4.4rCSI 12.6%PRS 64.1%
-
CSI 4.4rCSI 6.3%PRS 64.5%
-
CSI 4.4rCSI 14.2%PRS 72.2%
-
CSI 4.5rCSI 6.0%PRS 74.0%
-
CSI 4.5rCSI 4.1%PRS 87.7%
-
CSI 4.5rCSI 70.6%PRS 77.5%
-
CSI 4.5rCSI 3.5%PRS 90.1%
-
CSI 4.6rCSI 20.3%PRS 58.8%
-
CSI 4.6rCSI 4.5%PRS 67.6%
-
CSI 4.6rCSI 3.7%PRS 81.1%
-
CSI 4.7rCSI 4.2%PRS 72.9%
-
CSI 4.7rCSI 6.9%PRS 67.8%
-
CSI 4.8rCSI 7.8%PRS 64.3%
-
CSI 4.8rCSI 5.3%PRS 77.6%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 3970995465
Symbol: R3HD1_HUMAN
Name: R3H domain-containing protein 1
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 7584026
Title: Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1.
PubMed ID: 7584026
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 15815621
Title: Generation and annotation of the DNA sequences of human chromosomes 2 and 4.
PubMed ID: 15815621
DOI: 10.1038/nature03466
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 15144186
Title: Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.
PubMed ID: 15144186
DOI: 10.1021/ac035352d
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19690332
Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
PubMed ID: 19690332
PubMed ID: 20068231
Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
PubMed ID: 20068231
PubMed ID: 21406692
Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
PubMed ID: 21406692
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 24129315
Title: Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.
PubMed ID: 24129315
Sequence Information:
- Length: 1099
- Mass: 120696
- Checksum: 67782B9163702174
- Sequence:
MRMSDTVTVK DETATMKDLE AEVKDTTRVE NLIKSENYGK ILVEKNEHCI ENNIDLQRPL QSFGQTGKRS KSSSKLKLVR SLAVCEESPP PPAPEISQEN QEKIQIQLTQ SFEKEEKPSK DEAEKEKASD KLPRKMLSRD SSQEYTDSTG IDLHEFLVNT LKNNPRDRMM LLKLEQEILD FIGNNESPRK KFPPMTSYHR MLLHRVAAYF GLDHNVDQSG KSVIVNKTSN TRIPDQKFNE HIKDDKGEDF QKRYILKRDN SSFDKDDNQM RIRLKDDRRS KSIEEREEEY QRARDRIFSQ DSLCSQENYI IDKRLQDEDA SSTQQRRQIF RVNKDASGRS TNSHQSSTEN ELKYSEPRPW SSTDSDSSLR NLKPAVTKAS SFSGISVLTR GDSSGSSKSI GRLSKTGSES SGSVGSSTGS LSHIQQPLPG TALSQSSHGA PVVYPTVSTH SSLSFDGGLN GQVASPSTSF FLLPLEAAGI PPGSILINPQ TGQPFINPDG SPVVYNPPMT QQPVRSQVPG PPQPPLPAPP QQPAANHIFS QDNLGSQFSH MSLARQPSAD GSDPHAAMFQ STVVLQSPQQ SGYIMTAAPP PHPPPPPPPP PPPPPLPPGQ PVPTAGYPAS GHPVSQPVLQ QQGYIQQPSP QMPACYCAPG HYHSSQPQYR PVPSVHYNSH LNQPLPQPAQ QTGYQVIPNQ QQNYQGIVGV QQPQSQSLVS GQPNSIGNQI QGVVIPYTSV PTYQVSLPQG SQGIPHQTYQ QPVMFPNQSN QGSMPTTGMP VYYSVIPPGQ QNNLSSSVGY LQHPGSEQVQ FPRTTSPCSS QQLQGHQCTA GPPPPPGGGM VMMQLSVPNN PQSCAHSPPQ WKQNKYYCDH QRGQKCVEFS SVDNIVQHSP QLSSPIISPA QSPAPAQLST LKTVRPSGPP LSIMPQFSRP FVPGQGDSRY PLLGQPLQYN PPAVLHGHIP NQQGQPGSRH GNRGRRQAKK AASTDLGAGE TVVGKVLEIT ELPDGITRME AEKLFGELFK IGAKIRWLRD PQSQPRRHPL CCGSGDNTAN PERSKPSDLA STYTVLATFP SISAAQNALK KQINSVNKFK LRTSKKHYDF HILERASSQ